Page 4 - Laurae Niklason News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Laurae niklason. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Laurae Niklason Today - Breaking & Trending Today

Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 2,625,000 Shares

Humacyte, Inc. (NASDAQ:HUMA – Get Rating) CEO Laura E. Niklason sold 2,625,000 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $2.75, for a total transaction of $7,218,750.00. Following the completion of the sale, the chief executive officer now directly owns […] ....

Laurae Niklason , Swiss National Bank , York Mellon Corp , Humacyte Inc , Advisor Group Holdings Inc , Citigroup Inc , Blackrock Inc , Get Rating , Group Holdings , National Bank , New York Mellon Corp , Humacyte Daily , Nasdaq Huma , Insider Trading , Nsider Trades ,

$260,000.00 in Sales Expected for Humacyte, Inc. (NASDAQ:HUMA) This Quarter

Equities research analysts expect Humacyte, Inc. (NASDAQ:HUMA – Get Rating) to report sales of $260,000.00 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Humacyte’s earnings. The lowest sales estimate is $130,000.00 and the highest is $400,000.00. The company is expected to issue its next quarterly earnings report […] ....

United States , Laurae Niklason , William John Scheessele , Piper Sandler , Humacyte Company Profile Get Rating , Humacyte Inc , Mirabella Financial Services , Zacks Investment Research , Ensign Peak Advisors Inc , Eudaimonia Partners , Get Rating , Zacks Investment , Investment Research , Financial Services , General Partners , Peak Advisors Inc , California State Teachers Retirement System , State Teachers Retirement System , Company Profile , Nasdaq Huma ,

Analysts Expect Humacyte, Inc. (NASDAQ:HUMA) Will Post Quarterly Sales of $260,000.00

Wall Street brokerages forecast that Humacyte, Inc. (NASDAQ:HUMA – Get Rating) will report sales of $260,000.00 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Humacyte’s earnings, with estimates ranging from $120,000.00 to $400,000.00. The business is scheduled to announce its next earnings results on Friday, March 4th. […] ....

New York , United States , Laurae Niklason , Bradyw Dougan , Humacyte Company Profile Get Rating , Securities Exchange Commission , Zacks Investment Research , Exos Asset Management , Humacyte Inc , York Capital Management Global Advisors , Advisor Group Holdings Inc , Monashee Investment Management , Alpha Healthcare Acquisition Corp , Citigroup Inc , Wall Street , Get Rating , Zacks Investment , Director Brady , Exchange Commission , Investment Management , Group Holdings , Capital Management Global Advisors , Company Profile , Healthcare Acquisition , Nasdaq Huma ,